Agustín España
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Agustín España has a total of 287 co-authors. Here are the top co-authors by number of shared publications:
- Miguel Angel Idoate
Department of Pathology, Clínica Universidad de Navarra, Pamplona, Spain
14 shared publications - Pedro Redondo
Department of Dermatology University Clinic of Navarra Madrid Spain
12 shared publications - Alejandra Tomás-Velázquez
Department of Dermatology University Clinic of Navarra Madrid Spain
8 shared publications E. Quintanilla
Department of Dermatology University Clinic of Navarra, School of Medicine, Pamplona, Spain
7 shared publications- Elena Querol‐Cisneros
Department of Dermatology, University Clinic of Navarra, University of Navarra, IdiSNA, Navarra Institute for Health Research, Navarra, Spain
7 shared publications - Nuria Rodríguez-Garijo
Department of Dermatology, Clínica Universidad de Navarra, Pamplona, Spain
7 shared publications
Latest Publications
- 28 November 2024
- Published by Elsevier in Journal of the American Academy of Dermatology
- Vol. 92 (5) , 1084-1086
Long-term effectiveness and safety assessment of carbon dioxide laser treatment in Hailey-Hailey disease: A prospective cohort study
- 28 November 2024
- Published by Elsevier in Journal of the American Academy of Dermatology
- Vol. 92 (5) , 1084-1086
Long-term effectiveness and safety assessment of carbon dioxide laser treatment in Hailey-Hailey disease: A prospective cohort study
- 12 June 2024
- Published by Elsevier in Medicina Clinica
- Vol. 163 (5) , 232-237
Association between adipophilin expression and risk of dyslipidaemia in patients with granuloma annulare
- 12 June 2024
- Published by Elsevier in Medicina Clinica
- Vol. 163 (5) , 232-237
Association between adipophilin expression and risk of dyslipidaemia in patients with granuloma annulare
- 1 August 2023
- Published by JLE in European Journal Of Dermatology
- Vol. 33 (4) , 461-463
sQuiz your knowledge! A rare cause of abdominal mass following a cutaneous skin eruption
- 1 August 2023
- Published by JLE in European Journal Of Dermatology
- Vol. 33 (4) , 461-463
sQuiz your knowledge! A rare cause of abdominal mass following a cutaneous skin eruption
- 16 June 2023
- Published by Elsevier in Medicina Clínica (English Edition)
- Vol. 160 (12) , e11-e12
Microneedling with bleomycin as a treatment for periungueal and subungueal warts
- 16 June 2023
- Published by Elsevier in Medicina Clínica (English Edition)
- Vol. 160 (12) , e11-e12
Microneedling with bleomycin as a treatment for periungueal and subungueal warts
- 1 April 2023
- Published by Elsevier in Medicina Clinica
- Vol. 160 (12) , e11-e12
Microneedling with bleomycin as a treatment for periungueal and subungueal warts
- 1 April 2023
- Published by Elsevier in Medicina Clinica
- Vol. 160 (12) , e11-e12
Microneedling with bleomycin as a treatment for periungueal and subungueal warts
- Open Access
- 25 July 2022
- Published by Wiley in Experimental Dermatology
- Vol. 31 (10) , 1638-1640
Familial primary cutaneous amyloidosis: Caspase activation may be involved in amyloid formation
- 25 July 2022
- Published by Wiley in Experimental Dermatology
- Vol. 31 (10) , 1638-1640
Open AccessFamilial primary cutaneous amyloidosis: Caspase activation may be involved in amyloid formation
- Open Access
- 10 September 2021
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 12
Anti-Desmocollin Autoantibodies in Autoimmune Blistering Diseases
The presence of anti-desmocollin (Dsc) antibodies is rarely described in autoimmune blistering diseases patients. Moreover, several clinical phenotypes of pemphigus may be associated with these antibodies. In this review we analyze clinicopathological, immunologic and outcome features of anti-Dsc autoimmune blistering diseases patients, to improve their diagnosis and management. We conducted a systematic search of PubMed and Embase (1990-present) for studies reporting cases of autoimmune blistering diseases with anti-Dsc antibodies. We classified the selected patients as patients with exclusively anti-Dsc autoantibodies, and patients with anti-Dsc and other autoantibodies. Of 93 cases with anti-Dsc autoantibodies included, 38 (41%) had exclusively these antibodies. Only 18% of patients presented with the typical clinicopathological phenotype of pemphigus vulgaris or pemphigus foliaceous. Mucosal involvement was seen in approximately half of the patients. Up to 18% of cases were associated with neoplasms. Acantholysis was described in 54% of cases with histopathological information. Treatments and outcomes vary in the different clinical phenotypes. The presence of anti-Dsc antibodies must be suspected mainly in those patients with either atypical pemphigus, in special with clinical pustules, or in cases showing intraepithelial or dermal neutrophilic/eosinophilic infiltrate on histological examination and dual pattern by direct immunofluorescence examination.
- 10 September 2021
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 12
Open AccessAnti-Desmocollin Autoantibodies in Autoimmune Blistering Diseases
The presence of anti-desmocollin (Dsc) antibodies is rarely described in autoimmune blistering diseases patients. Moreover, several clinical phenotypes of pemphigus may be associated with these antibodies. In this review we analyze clinicopathological, immunologic and outcome features of anti-Dsc autoimmune blistering diseases patients, to improve their diagnosis and management. We conducted a systematic search of PubMed and Embase (1990-present) for studies reporting cases of autoimmune blistering diseases with anti-Dsc antibodies. We classified the selected patients as patients with exclusively anti-Dsc autoantibodies, and patients with anti-Dsc and other autoantibodies. Of 93 cases with anti-Dsc autoantibodies included, 38 (41%) had exclusively these antibodies. Only 18% of patients presented with the typical clinicopathological phenotype of pemphigus vulgaris or pemphigus foliaceous. Mucosal involvement was seen in approximately half of the patients. Up to 18% of cases were associated with neoplasms. Acantholysis was described in 54% of cases with histopathological information. Treatments and outcomes vary in the different clinical phenotypes. The presence of anti-Dsc antibodies must be suspected mainly in those patients with either atypical pemphigus, in special with clinical pustules, or in cases showing intraepithelial or dermal neutrophilic/eosinophilic infiltrate on histological examination and dual pattern by direct immunofluorescence examination.
- 15 February 2021
- Published by Wiley in JDDG: Journal der Deutschen Dermatologischen Gesellschaft
- Vol. 19 (2) , 265-267
Bullöses Pemphigoid ohne Autoantikörper bei einem Psoriasis‐Patienten unter Ustekinumab‐Therapie
- 15 February 2021
- Published by Wiley in JDDG: Journal der Deutschen Dermatologischen Gesellschaft
- Vol. 19 (2) , 265-267
Bullöses Pemphigoid ohne Autoantikörper bei einem Psoriasis‐Patienten unter Ustekinumab‐Therapie
- 1 February 2021
- Published by Wiley in JDDG: Journal der Deutschen Dermatologischen Gesellschaft
- Vol. 19 (2) , 265-267
Bullous pemphigoid without detection of autoantibodies in a patient with psoriasis under ustekinumab
- 1 February 2021
- Published by Wiley in JDDG: Journal der Deutschen Dermatologischen Gesellschaft
- Vol. 19 (2) , 265-267
Bullous pemphigoid without detection of autoantibodies in a patient with psoriasis under ustekinumab